BackAlar Pharmaceuticals Overview

Alar Pharmaceuticals Receivables

Track Alar Pharmaceuticals's receivables ($260K) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Receivables
$263000.00

Peer trimmed avg / median

Loading

Alar Pharmaceuticals Receivables History

Loading

Alar Pharmaceuticals vs. peers: Receivables Comparison

Loading

Alar Pharmaceuticals Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Alar Pharmaceuticals (6785.TWO) FAQ

The latest receivables for 6785.TWO is $260K as of June 2026. In the prior-year period, the figure was $0. Investors often review this figure alongside Alar Pharmaceuticals's historical trend and sector peers before judging valuation or financial health.

Over the past year, 6785.TWO's receivables moved from $0 to $260K. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Alar Pharmaceuticals's operating scale or balance-sheet position.

A receivables figure of $260K for 6785.TWO is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting 6785.TWO's receivables ($260K), review year-over-year change from $0, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.